Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Recent Posts
- CereMark Pharma Begins Phase III Trial of F-18 Flornaptitril, a Novel Diagnostic Radiopharmaceutical Focused on Neurodegeneration
- CereMark Pharma and Hall of Fame Health Team Up to Investigate the Clinical Progression of Neurodegeneration in Athletes and Soldiers
- CereMark Pharma and Invicro to Collaborate on the Development of F-18 Flornaptitril
- CereMark Pharma Announces New Patents on Selective Imaging Agent of Alzheimer’s Disease, Chronic Traumatic Encephalopathy and Other Neurodegenerative Diseases
- Patent Awarded for PET Radiopharmaceutical for Neurodegeneration Imaging
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.